Absolute and Fast Removal of Viruses and Bacteria from Water by Spraying-Assembled Carbon-Nanotube Membranes.

Membrane separation is able to efficiently remove pathogens like bacteria and viruses from water based on size exclusion. However, absolute and fast removal of pathogens requires highly permeable but selective membranes. Herein, we report the preparation of such advanced membranes using carbon nanotubes (CNTs) as one-dimensional building blocks. We first disperse CNTs with the help of an amphiphilic block copolymer, poly(2-dimethylaminoethyl methacrylate)-block-polystyrene (PDMAEMA-b-PS, abbreviated as BCP). The PS blocks adsorb on the surface of CNTs via the π-π interaction, while the PDMAEMA blocks are solvated, thus forming homogeneous and stable CNT dispersions. We then spray the CNT dispersions on porous substrates, producing composite membranes with assembled CNT layers as the selective layers. We demonstrate that the optimized membrane shows 100% rejection to phage viruses and bacteria (Escherichia coli) while giving a water permeance up to ∼3300 L m-2 h-1 bar-1. The performance of the resultant BCP/CNT membrane outperforms that of state-of-the-art membranes and commercial membranes. The BCP/CNT membrane can be used for multiple runs and regenerated by water rinsing. Membrane modules assembled from large-area membrane sheets sustain the capability of absolute and fast removal of viruses and bacteria.

A versatile dilution-treatment-detection microfluidic chip platform for rapid In vitro lung cancer drug combination sensitivity evaluation.

Combination drug therapy represents an effective strategy for treating certain drug-resistant and intractable cancer cases. However, determining the optimal combination of drugs and dosages is challenging due to clonal diversity in patients' tumors and the lack of rapid drug sensitivity evaluation methods. Microfluidic technology offers promising solutions to this issue. In this study, we propose a versatile microfluidic chip platform capable of integrating all processes, including dilution, treatment, and detection, for in vitro drug sensitivity assays. This platform innovatively incorporates several modules, including automated discrete drug logarithmic concentration generation, on-chip cell perfusion culture, and parallel drug treatments of cancer cell models. Moreover, it is compatible with microplate readers or high-content imaging systems for swift detection and automated monitoring, simplifying on-chip drug evaluation. Proof of concept is demonstrated by assessing the in vitro potency of two drugs, cisplatin, and etoposide, against the lung adenocarcinoma A549 cell line, under both single-drug and combination treatment conditions. The findings reveal that, compared to conventional microplate approaches with static cultivation, this on-chip automated perfusion bioassays yield comparable IC50 values with lower variation and a 50 % reduction in drug preparation time. This versatile dilution-treatment-detection microfluidic platform offers a promising tool for rapid and precise drug assessments, facilitating in vitro drug sensitivity evaluation in personalized cancer chemotherapy.